Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel Interactive Tool for Breast and Ovarian Cancer Risk Assessment (Bright Pink Assess Your Risk): Development and Usability Study.

Journal of medical Internet research - 24 Feb 2022

Hibler Elizabeth A, Fought Angela J, Kershaw Kiarri N, Molsberry Rebecca, Nowakowski Virginia, Lindner Deborah

Abstract excerpt

BACKGROUND: The lifetime risk of breast and ovarian cancer is significantly higher among women with genetic susceptibility or a strong family history. However, current risk assessment tools and clinical practices may identify only 10% of asymptomatic carriers of susceptibility genes. Bright Pink developed the Assess Your Risk (AYR) tool to estimate breast and ovarian cancer risk through a user-friendly,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Ovarian Neoplasms

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 35200148
DOI: 10.2196/29124
PMCID: PMC8914739

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel Interactive Tool for Breast and Ovarian Cancer Risk Assessment (Bright Pink Assess Your Risk): Development and Usability Study.PMID 35200148Read ↗

CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants.Semantic proximity Read ↗

Risk Assessment, Genetic Counseling, and Genetic Testing forBRCA-Related Cancer in WomenSemantic proximity Read ↗

Protocol for Health Risk Information Technology-Assisted Genetic Evaluation (HeRITAGE): a randomised controlled trial of digital genetic cancer risk assessment in a diverse underserved gynaecology clinic.Semantic proximity Read ↗

Implementing Integrated Genomic Risk Assessments for Breast Cancer: Lessons Learned from the eMERGE StudySemantic proximity Read ↗

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.Semantic proximity Read ↗

Personalized assessment and management of women at risk for breast cancer in North America.Semantic proximity Read ↗

Results of breast cancer risk assessment and hereditary cancer genetic testing in community obstetrics and gynaecology practice following a prospective quality Improvement initiative.Semantic proximity Read ↗

The Pink Underside: The Commercialization of Medical Risk Assessment and Decision-Making Tools for Hereditary Breast Cancer Risk.Semantic proximity Read ↗

Integration and usability of a digital cancer risk stratification tool to optimize identification of patients at risk for hereditary cancers: A pilot study.Semantic proximity Read ↗

Clinically relevant lessons from Family HealthLink: a cancer and coronary heart disease familial risk assessment tool.Semantic proximity Read ↗

Preliminary validation of a consumer-oriented colorectal cancer risk assessment tool compatible with the US Surgeon General's My Family Health Portrait.Semantic proximity Read ↗

The co-design, development, and preliminary evaluation of a comprehensive breast cancer risk report incorporating polygenic risk informationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.